Home
Suven Life Sciences Limited
Press Release Apr 15 2024
Business
Apr 15 2024
3 min read

Press Release Apr 15 2024

Suven Life Sciences Limited has informed the Exchange regarding a press release dated April 15, 2024, titled "Suven Life Sciences to present Phase-2 Positive Results on Samelisant (SUVN-G3031) at American Academy of Neurology (AAN) 2024 Annual Meeting, Denver, USA".

View Attachment